Continue with FacebookLooking to list your PhD opportunities? Log in here.
Dr Sally Freeman,
Dr Andrew Leach,
Prof David Brough,
Dr Jack Green
Applications accepted all year round
Self-Funded PhD Students Only
Manchester
United Kingdom
Computational Chemistry
Neurology
Neuroscience
Organic Chemistry
Pharmaceutical Chemistry
Pharmacy
Synthetic Chemistry
About the Project
Inflammation is a contributing factor in a range of therapeutic areas including stroke, Alzheimer’s disease and cancer. A cause of Inflammation is through the activation of multi-protein complexes called inflammasomes, which facilitates the release of cytokines, including IL-1b. Our research team has designed inhibitors for the NLRP3 inflammasome. In this project we focus on the design and development of novel inhibitors for the AIM-2 inflammasome, of particular relevance to the early treatment of stroke. AIM-2 binds to polyanionic DNA, therefore here we will computationally design (supervised by Dr Leach), synthesise and characterise (supervised by Dr Freeman) and evaluate in relevant biology models (collaboration with Prof Brough and Dr Green).
Entry Requirements
Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in, for example, chemistry, pharmacy, pharmaceutical sciences, medicinal chemistry, natural sciences. Candidates with experience or interest in synthesis or computational chemistry linked to drug design are encouraged to apply.
How to Apply
For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/). Informal enquiries may be made directly to the primary supervisor. On the online application form select the PhD title Pharmacy & Pharmaceutical Sciences.
For international students, we also offer a unique 4 year PhD programme that gives you the opportunity to undertake an accredited Teaching Certificate whilst carrying out an independent research project across a range of biological, medical and health sciences. For more information please visit www.internationalphd.manchester.ac.uk
Equality, Diversity & Inclusion
Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website
https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/
Funding Notes
Applications are invited from self-funded students.
This project has a Band 2 fee. Details of our different fee bands can be found on our website View Website
This project has a Band 2 fee. Details of our different fee bands can be found on our website View Website
References
T Swanton, JA Beswick, H Hammadi, L Morris, D Williams, S de Cesco, L El-Sharkawy, S Yu, J Green, JB Davis, CB Lawrence, D Brough*, S Freeman*. Selective inhibition of the K+ efflux sensitive NLRP3 pathway by Cl- channel modulation. Chem. Sci., 2020, 11, 11720-11728.
Email Now
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
Why not add a message here
* required field
The information you submit to The University of Manchester will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Manchester, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs
PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
University of Bradford
Structure based design of novel warheads for use in peptide-drug conjugates
The University of Manchester
Novel hybrid modelling approach and solution algorithms for optimal synthesis and design of industrial CO2 utilisation processes
The University of Manchester